Sanguine Media Limited Conducts Independent Directors Meeting Under SEBI Regulations
Sanguine Media Limited successfully conducted its annual independent directors meeting on March 20, 2026, lasting 30 minutes from 3:00 PM to 3:30 PM at the registered office. The meeting, held in compliance with SEBI (LODR) Regulations and Companies Act requirements, involved comprehensive reviews of board performance, chairperson evaluation, and assessment of information flow between management and directors. The outcome was formally communicated to BSE Limited by Director Aditya R Suryavanshi, demonstrating the company's commitment to regulatory compliance and corporate governance standards.
*this image is generated using AI for illustrative purposes only.
Sanguine Media Limited has informed BSE Limited about the successful completion of its independent directors meeting held on March 20, 2026, as mandated under Regulation 25(3) of the SEBI (LODR) Regulations, 2015 and Schedule IV of the Companies Act, 2013.
Meeting Details and Regulatory Compliance
The meeting was conducted at the company's registered office for the Financial Year 2025-26, demonstrating the company's commitment to corporate governance standards. The session was presided over by the independent directors present and lasted for 30 minutes.
| Parameter: | Details |
|---|---|
| Meeting Date: | March 20, 2026 |
| Duration: | 3:00 PM to 3:30 PM |
| Location: | Registered Office |
| Regulatory Framework: | SEBI (LODR) Regulations, 2015 |
Key Agenda Items Reviewed
The independent directors conducted a comprehensive evaluation covering multiple aspects of corporate governance:
- Board Performance Review: Assessed the performance of non-independent directors and evaluated the board of directors as a collective entity
- Chairperson Evaluation: Reviewed the performance of the company's chairperson, incorporating feedback from both executive and non-executive directors
- Information Flow Assessment: Evaluated the quality, quantity, and timeliness of information exchange between management and the board to ensure directors can perform their duties effectively
Corporate Communication
The outcome was communicated to BSE Limited through a formal letter signed by Aditya R Suryavanshi, Director (DIN: 07703306), ensuring transparency and regulatory compliance. The company maintains its registered office at Plot No 135A, 1st Floor, Chandran Nagar Main Road Chromepet, Chennai - 600044, Tamil Nadu.
This annual independent directors meeting represents a crucial component of Sanguine Media Limited's corporate governance framework, ensuring independent oversight and evaluation of the company's leadership and operational processes.
What specific governance improvements or strategic changes might emerge from the board performance evaluation findings?
How could the independent directors' assessment of information flow impact Sanguine Media's future board decision-making processes?
Will the chairperson evaluation results lead to any modifications in leadership structure or board composition for FY 2026-27?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
